Hipometilirajući agens

Izvor: Wikipedija
(Preusmjereno sa stranice Inhibitor DNK metilacije)
Prijeđi na navigaciju Prijeđi na pretragu

Hipometilirajući agens je lek koji inhibira metilaciju DNK.

Termin „demetilirajući agens“ se takođe koristi.[1]

Lekovi ove grupe se ispituju za moguću primenu u tretmanu tumora.[2]

Primeri

Reference[uredi | uredi kod]

  1. Garcia-Manero G (November 2008). „Demethylating agents in myeloid malignancies”. Curr Opin Oncol 20 (6): 705–10. DOI:10.1097/CCO.0b013e328313699c. PMID 18841054. 
  2. Hambach L, Ling KW, Pool J, et al. (December 2008). „Hypomethylating drugs convert HA-1 negative solid tumors into targets for stem cell based immunotherapy”. Blood 113 (12): 2715–22. DOI:10.1182/blood-2008-05-158956. PMID 19096014. 
  3. Aribi A, Borthakur G, Ravandi F, et al. (February 2007). „Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia”. Cancer 109 (4): 713–7. DOI:10.1002/cncr.22457. PMID 17219444. 
  4. De Padua Silva L, de Lima M, Kantarjian H, et al. (January 2009). „Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome”. Bone Marrow Transplant. 43 (11): 839–43. DOI:10.1038/bmt.2008.400. PMID 19151791. 
  5. Garcia-Manero G, Stoltz ML, Ward MR, Kantarjian H, Sharma S (September 2008). „A pilot pharmacokinetic study of oral azacitidine”. Leukemia 22 (9): 1680–4. DOI:10.1038/leu.2008.145. PMID 18548103. 

Vidi još[uredi | uredi kod]